ANTX vs TOST · $32.0M cap vs P/E 161, rev $3.54B
AN2 Therapeutics Inc (ANTX) versus Toast Inc (TOST) — a side-by-side from cached financials, not a winner call.
AN2 Therapeutics Inc (ANTX) is a biotechnology company listed on US.
Toast Inc (TOST) is a software - infrastructure company listed on US.
ANTX does not have a complete income-statement cache yet.
Latest reported TOST revenue for 2026-06-30 was $3.54B. Net income was $280.0M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
ANTX currently screens at market cap $32.0M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
Not investment advice. Open the ANTX and TOST stock pages for the full models.
Not investment advice.